EW: Summary for EDWARDS LIFESCIENCES - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 4:43am EST - Canadian Markets open in 4 hours and 47 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Edwards Lifesciences Corp. (EW)

On Feb 9: 86.65 USD 0.00 (0.00%)

MORE ON EW

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

EDWARDS LIFESCIENCES (NYSE:EW) Delayed quote data

Last Trade:	86.65 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	86.65
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	94.90

Day's Range:	N/A - N/A
52wk Range:	52.86 - 94.55
Volume:	0
Avg Vol (3m):	337,676
Market Cap:	4.90B
P/E (ttm):	23.08
EPS (ttm):	3.76
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add EW to Portfolio

Download Data

HEADLINES

•	New Star Analyst Rankings for EDWARDS LIFESCIENCES
	StarMine (Sat, Feb 6)

•	New Device Promises To Make Heart Surgery Easier And Safer
	Investor's Business Daily (Fri, Feb 5)

•	Edwards Lifesciences Corp. Q4 2009 Earnings Call Transcript
	at Seeking Alpha (Fri, Feb 5)

•	UPDATE - Edwards 4th-quarter profit rises 25 percent
	at Reuters (Thu, Feb 4)

•	Earnings roundup: Power-One, FIS
	AP (Thu, Feb 4)

•	Edwards Lifesciences 4Q profit rises 25 percent
	AP (Thu, Feb 4)

•	EDWARDS LIFESCIENCES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
	EDGAR Online (Thu, Feb 4)

•	Edwards Lifesciences Reports Strong Fourth Quarter Results
	Marketwire (Thu, Feb 4)

•	Q4 2009 Edwards Lifesciences Earnings Release - Time Not Supplied
	CCBN (Thu, Feb 4)

•	Five Mid-Cap Stocks Ready to Break Out
	at TheStreet.com (Thu, Feb 4)

More Headlines for EW...

ANALYST

EPS Est (next year) (Dec-10) :	3.55
EPS Est (in 2 years) (Dec-11) :	4.20
Avg Rec (current)*:	2.2
PEG Ratio:	1.32

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Edwards Lifesciences Corporation provides products and technologies designed to treat cardiovascular diseases. It provides products and technologies for heart valve therapy, critical care, cardiac surgery systems, and vascular disease.

Full Company Profile

Add to Portfolio

Email to a Friend

•